Home > Insider Trading > Filing (0001104659-21-082832)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1613859	Pra Health Sciences Inc.	PRAH	Services-Commercial Physical & Biological Research (8731)	463640387

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1738327	J. Michael Bonello	C/O Pra Health Sciences, Inc. 4130 Parklake Avenue, Suite 400 Raleigh NC 27612	Evp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-15	14,000	$75.81	35,867	No	4	M	Direct
Common Stock	Acquisiton	2021-06-15	7,123	$81.61	42,990	No	4	M	Direct
Common Stock	Disposition	2021-06-15	30,279	$168.27	12,711	No	4	S	Direct
Common Stock	Disposition	2021-06-15	847	$168.80	11,864	No	4	S	Direct
Common Stock	Acquisiton	2021-06-16	17,216	$81.61	29,080	No	4	M	Direct
Common Stock	Disposition	2021-06-16	16,316	$166.41	12,764	No	4	S	Direct
Common Stock	Disposition	2021-06-16	900	$167.49	11,864	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-15	14,000	$0.00	14,000	$75.81
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-15	7,123	$0.00	7,123	$81.61
Common Stock	Stock Options (Right to Buy)	Disposition	2021-06-16	17,216	$0.00	17,216	$81.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,000		2027-08-29	No	4	M	Direct
72,877	2019-04-26	2028-04-26	No	4	M	Direct
55,661		2028-04-26	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.69 to $168.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.70 to $168.94, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.07 to $167.01, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.10 to $168.04, inclusive.
4,000 options vested on August 29, 2018; 4,000 options vested on August 29, 2019 and 6,000 options vested on August 29, 2020 upon satisfaction of certain performance criteria.
12,877 options vested on April 26, 2019 and 4,339 options vested on April 26, 2020 upon satisfaction of certain performance criteria.